Amsterdam institute for Immunology and Infectious diseases
-
Impact of rituximab maintenance on survival in patients with mantle cell lymphoma: a population-based cohort study
Stedema, F., Brink, M., Huisman, F., van Rijn, R., Sijs- Szabo, A., Nijhof, I., Diepstra, A., Vergote, V., van Gorkum, G., Flinsenberg, T., Huls, G., van Meerten, T., Doorduijn, J., Plattel, W. & Nijland, M., 12 May 2026, In: Blood. 10, 9, p. 2916-2924 9 p.Research output: Contribution to Journal › Article › Academic › peer-review
-
Inpatient Vs. Outpatient Treatment Management With Teclistamab in Relapsed and Refractory Multiple Myeloma: A Cost and Healthcare Resource Utilization Analysis
van de Donk, N., Wester, R., Nijhof, I., Albrecht, C., Morano, R. & Entrala, C., 1 Jan 2026, In: Haematologica. 111, P50.Research output: Contribution to Journal › Article › Academic › peer-review
-
Uncovering the ultra-frail: A distinct subgroup in non-transplant eligible newly diagnosed patients with multiple myeloma, with an inferior clinical outcome
Groen, K., Smits, F., Nasserinejad, K., Levin, M.-D., Regelink, J. C., Timmers, G.-J., de Waal, E. G. M., Westerman, M., Velders, G. A., de Heer, K., Leys, R. B. L., van Kampen, R. J. W., Stege, C. A. M., Seefat, M. R., Nijhof, I. S., van der Spek, E., Klein, S. K., van de Donk, N. W. C. J., Ypma, P. F. & Zweegman, S., 1 Dec 2025, In: HemaSphere. 9, 12, e70268.Research output: Contribution to Journal › Comment / Letter to the editor › Academic
- All publications